Literature DB >> 34450652

RE: Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer.

Ashley M Hopkins1, Ganessan Kichenadasse1,2, Jessica M Logan3, Andrew Rowland1, Michael J Sorich1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34450652      PMCID： PMC8902332          DOI： 10.1093/jnci/djab159

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   11.816


× No keyword cloud information.
  6 in total

Review 1.  Biomarker: Predictive or Prognostic?

Authors:  Karla V Ballman
Journal:  J Clin Oncol       Date:  2015-09-21       Impact factor: 44.544

2.  Development and Validation of a Prognostic Model for Patients with Advanced Lung Cancer Treated with the Immune Checkpoint Inhibitor Atezolizumab.

Authors:  Andrew Rowland; Michael J Sorich; Ashley M Hopkins; Ganessan Kichenadasse; Elizabeth Garrett-Mayer; Christos S Karapetis
Journal:  Clin Cancer Res       Date:  2020-02-21       Impact factor: 12.531

Review 3.  Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers.

Authors:  Ashley M Hopkins; Andrew Rowland; Ganessan Kichenadasse; Michael D Wiese; Howard Gurney; Ross A McKinnon; Chris S Karapetis; Michael J Sorich
Journal:  Br J Cancer       Date:  2017-08-24       Impact factor: 7.640

Review 4.  Smokers or non-smokers: who benefits more from immune checkpoint inhibitors in treatment of malignancies? An up-to-date meta-analysis.

Authors:  Jiahang Mo; Xiao Hu; Lihu Gu; Bangsheng Chen; Parikshit Asutosh Khadaroo; Zefeng Shen; Lei Dong; Yuqi Lv; Marylin Nyaradzo Chitumba; Jiequan Liu
Journal:  World J Surg Oncol       Date:  2020-01-20       Impact factor: 2.754

5.  The effect of smoking status on efficacy of immune checkpoint inhibitors in metastatic non-small cell lung cancer: A systematic review and meta-analysis.

Authors:  Linzheng Dai; Bo Jin; Tingting Liu; Jun Chen; Guang Li; Jun Dang
Journal:  EClinicalMedicine       Date:  2021-06-26

6.  Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer.

Authors:  Xinan Wang; Biagio Ricciuti; Joao V Alessi; Tom Nguyen; Mark M Awad; Xihong Lin; Bruce E Johnson; David C Christiani
Journal:  J Natl Cancer Inst       Date:  2021-06-11       Impact factor: 11.816
  6 in total
  1 in total

1.  Response to Hopkins, Kichenadasse, Logan, et al.

Authors:  Xinan Wang; Biagio Ricciuti; Joao V Alessi; Tom Nguyen; Mark M Awad; Xihong Lin; Bruce E Johnson; David C Christiani
Journal:  J Natl Cancer Inst       Date:  2022-03-08       Impact factor: 11.816
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.